Targeting mitochondria to treat heart failure
Synergistically Target Mitochondria for Heart Failure Treatment
This study is looking at how problems with tiny energy factories in heart cells, called mitochondria, can lead to heart failure, and it's working on new treatments that could help keep these factories running well and protect the heart from damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10825544 on NIH RePORTER |
What this research studies
This research investigates the role of mitochondria in heart failure, focusing on how defects in mitochondrial function contribute to the disease. The approach aims to develop therapies that can both preserve mitochondrial membrane potential and reduce harmful reactive oxygen species in heart cells. By using advanced techniques to assess mitochondrial function in live animals, the research seeks to identify effective treatments that could improve heart health and patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with heart failure who may benefit from innovative mitochondrial-targeted therapies.
Not a fit: Patients with heart failure caused by non-mitochondrial factors may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve the treatment of heart failure.
How similar studies have performed: While antioxidant therapies have shown promise in preclinical studies, this approach of synergistically targeting mitochondrial function is novel and has not been extensively tested in clinical settings.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Zhou, Lufang — Ohio State University
- Study coordinator: Zhou, Lufang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.